clinical-trial-protocol-skill

Warn

Audited by Snyk on Jul 16, 2026

Risk Level: MEDIUM
Full Analysis

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

  • Third-party content exposure detected (high risk: 0.75). The required workflow’s Step 1/Research step is described as reading and executing references/01-research-protocols.md on-demand, which (per the skill’s stated purpose) performs clinical-trial/FDA research via external MCP tools and database URLs, ingesting outsider-authored free text (e.g., trial eligibility/outcomes/guidance excerpts) into the LLM context.

Issues (1)

W011
MEDIUM

Third-party content exposure detected (indirect prompt injection risk).

Audit Metadata
Risk Level
MEDIUM
Analyzed
Jul 16, 2026, 10:42 AM
Issues
1